Stay updated on FLX475 Dose Escalation Trial in Combination With Pembrolizumab

Sign up to get notified when there's something new on the FLX475 Dose Escalation Trial in Combination With Pembrolizumab page.
Latest website image capture
Clouds background image

Latest updates to the FLX475 Dose Escalation Trial in Combination With Pembrolizumab page

  1. Check
    6 days ago
    No Change Detected
  2. Check
    13 days ago
    Change Detected
    Summary
    Minor administrative update to the study record, such as a new last update timestamp, with no changes to core study design, eligibility criteria, interventions, or primary outcomes. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.3%
    Check dated 2025-10-27T20:56:09.000Z thumbnail image
  3. Check
    34 days ago
    Change Detected
    Summary
    Added a prominent operating-status notice and a v3.2.0 version tag, replacing the prior v3.1.0 revision.
    Difference
    4%
    Check dated 2025-10-06T07:55:59.000Z thumbnail image
  4. Check
    41 days ago
    Change Detected
    Summary
    Overall, the page has been updated to a new version (v3.1.0) with the removal of a prior disease reference (Head and neck squamous cell carcinoma).
    Difference
    0.4%
    Check dated 2025-09-29T04:15:44.000Z thumbnail image
  5. Check
    56 days ago
    Change Detected
    Summary
    Updated to Revision: v3.0.2 and removed the 'Back to Top' link.
    Difference
    0.2%
    Check dated 2025-09-14T22:08:15.000Z thumbnail image
  6. Check
    63 days ago
    Change Detected
    Summary
    The web page has been updated from version 3.0.0 to version 3.0.1, indicating a revision in the content. There are no significant changes in core content, pricing, or availability.
    Difference
    0.2%
    Check dated 2025-09-07T19:15:39.000Z thumbnail image
  7. Check
    70 days ago
    Change Detected
    Summary
    The webpage has undergone significant updates, including the addition of new facility names and locations, as well as a comprehensive list of related medical topics and diseases, while removing outdated location references and certain medical terms.
    Difference
    11%
    Check dated 2025-08-31T12:22:02.000Z thumbnail image

Stay in the know with updates to FLX475 Dose Escalation Trial in Combination With Pembrolizumab

Enter your email address, and we'll notify you when there's something new on the FLX475 Dose Escalation Trial in Combination With Pembrolizumab page.